With escalating numbers of opioid overdoses in the United States, there is a pressing need for digital health and technology to tackle the growing epidemic, and formulate new strategies to supplement standard treatment approaches. emocha, a Baltimore-based startup that uses a mobile application to improve medication adherence while strengthening patient-provider relationships, is listed as one of the top technology startups fighting substance in the country. CEO of emocha Sebastian Seiguer states that the platform “helps establish trust between patients and care teams, connecting them between in-person appointments. Having a touchpoint with a patient at every dose improves retention in care, while our mobile technology makes those interactions scalable across large populations of patients.” 

Read the full article in MedTech Boston